Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical operating margin
Operating margin is operating income as a percentage of revenue.
Rockwell Medical's operating margin for the twelve months ending Jun 30, 2026 was -6.5%. For fiscal 2025 it was -6.8%, against 0.6% the year before. The highest annual figure on record is 0.6% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -6.8% | −7.4 |
| FY2024 | Dec 31, 2024 | 0.6% | +8.6 |
| FY2023 | Dec 31, 2023 | -8.0% | +15.1 |
| FY2022 | Dec 31, 2022 | -23.0% | +25.9 |
| FY2021 | Dec 31, 2021 | -49.0% | −3.3 |
| FY2020 | Dec 31, 2020 | -45.7% | +10.6 |
| FY2019 | Dec 31, 2019 | -56.3% | −5.1 |
| FY2018 | Dec 31, 2018 | -51.2% | −5.9 |
| FY2017 | Dec 31, 2017 | -45.2% | −7.3 |
| FY2016 | Dec 31, 2016 | -37.9% | −10.6 |
| FY2015 | Dec 31, 2015 | -27.3% | +5.1 |
| FY2014 | Dec 31, 2014 | -32.4% | +57.4 |
| FY2013 | Dec 31, 2013 | -89.8% | +19.0 |
| FY2012 | Dec 31, 2012 | -108.9% | −64.6 |
| FY2011 | Dec 31, 2011 | -44.3% | −39.5 |
| FY2010 | Dec 31, 2010 | -4.8% | +5.2 |
| FY2009 | Dec 31, 2009 | -10.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -6.0% | +2.4 |
| Q1 FY2026 | Mar 31, 2026 | -8.5% | −1.3 |
| Q4 FY2025 | Dec 31, 2025 | -2.2% | −0.1 |
| Q3 FY2025 | Sep 30, 2025 | -9.9% | −16.8 |
| Q2 FY2025 | Jun 30, 2025 | -8.4% | −10.4 |
| Q1 FY2025 | Mar 31, 2025 | -7.2% | −1.4 |
| Q4 FY2024 | Dec 31, 2024 | -2.1% | +0.4 |
| Q3 FY2024 | Sep 30, 2024 | 6.8% | +14.1 |
| Q2 FY2024 | Jun 30, 2024 | 2.0% | +18.4 |
| Q1 FY2024 | Mar 31, 2024 | -5.8% | +1.4 |
| Q4 FY2023 | Dec 31, 2023 | -2.5% | +7.7 |
| Q3 FY2023 | Sep 30, 2023 | -7.3% | +12.5 |
| Q2 FY2023 | Jun 30, 2023 | -16.4% | +7.6 |
| Q1 FY2023 | Mar 31, 2023 | -7.3% | +33.8 |
| Q4 FY2022 | Dec 31, 2022 | -10.2% | +44.3 |
| Q3 FY2022 | Sep 30, 2022 | -19.8% | +23.8 |
| Q2 FY2022 | Jun 30, 2022 | -24.0% | +27.7 |
| Q1 FY2022 | Mar 31, 2022 | -41.1% | +5.3 |
| Q4 FY2021 | Dec 31, 2021 | -54.5% | −1.3 |
| Q3 FY2021 | Sep 30, 2021 | -43.6% | +0.2 |
| Q2 FY2021 | Jun 30, 2021 | -51.7% | −16.4 |
| Q1 FY2021 | Mar 31, 2021 | -46.4% | +4.4 |
| Q4 FY2020 | Dec 31, 2020 | -53.2% | −5.4 |
| Q3 FY2020 | Sep 30, 2020 | -43.8% | +7.8 |
| Q2 FY2020 | Jun 30, 2020 | -35.2% | +34.6 |
| Q1 FY2020 | Mar 31, 2020 | -50.8% | +5.8 |
| Q4 FY2019 | Dec 31, 2019 | -47.8% | +8.1 |
| Q3 FY2019 | Sep 30, 2019 | -51.5% | −21.6 |
| Q2 FY2019 | Jun 30, 2019 | -69.9% | +12.6 |
| Q1 FY2019 | Mar 31, 2019 | -56.6% | −18.4 |
| Q4 FY2018 | Dec 31, 2018 | -55.9% | +6.2 |
| Q3 FY2018 | Sep 30, 2018 | -30.0% | +4.4 |
| Q2 FY2018 | Jun 30, 2018 | -82.5% | −31.7 |
| Q1 FY2018 | Mar 31, 2018 | -38.3% | −4.3 |
| Q4 FY2017 | Dec 31, 2017 | -62.1% | −22.8 |
| Q3 FY2017 | Sep 30, 2017 | -34.4% | +2.7 |
| Q2 FY2017 | Jun 30, 2017 | -50.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -34.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -39.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -37.1% | – |
See a number that looks wrong?